MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-26-0163309
Elara Pharmaceuticals Private Limited
Elara Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹68.52 Lakh
▲ 24% YoY
Net profit · FY 2025
₹4.24 Lakh
Net margin 6.2%
EBITDA · FY 2025
₹6.46 Lakh
EBITDA margin 9.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹13.01 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
4
As per MCA filings
About Elara Pharmaceuticals Private Limited
Data last updated:
Elara Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24299PN2021PTC204056. Its GSTIN is 27AAGCE6368N1ZY (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Narayan Zendekar and Sachin Chandrakant Nakade.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gat No.1236 Datta Nagar 10th Mail Haveli Wadki, Pune, Maharashtra, India – 412308.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.52 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹4.24 Lakh (net margin 6.2%) and EBITDA of ₹6.46 Lakh (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 145% over three years.
As per MCA filings, the company has open charges of ₹13.01 Lakh on record.
Elara Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0163309).
Company details
CIN U24299PN2021PTC204056
Registration Number 204056
Incorporation Date 07 September 2021
ROC Pune
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0163309
Key People
Narayan Zendekar Director Sachin Chandrakant Nakade Director Amar Ankush Dhaygude Director Recognitions & Rankings of Elara Pharmaceuticals
Contact details
Elara Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGat No.1236 Datta Nagar 10th Mail Haveli Wadki, Pune, Maharashtra, India – 412308
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Elara Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Elara Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Elara Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Elara Pharmaceuticals Private Limited, buy the company report.
Financials of Elara Pharmaceuticals Private Limited
FY 2025 filings availableElara Pharmaceuticals Private Limited reported revenue of ₹68.52 Lakh (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹68.52 Lakh ▲ 24%
Net profit · FY 2025
₹4.24 Lakh margin 6.2%
EBITDA · FY 2025
₹6.46 Lakh margin 9.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 145%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 63%
Revenue has grown at a compounded annual rate (CAGR) of 145% over three years, including 24% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹6.46 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹4.24 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9.4% | |||
| Net Profit Margin | 6.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Elara Pharmaceuticals Private Limited, buy the company report.
Board of directors of Elara Pharmaceuticals Private Limited
Elara Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narayan Zendekar | Director | 07 Sep 2021 | 5 Years 2 Months | Current |
| Sachin Chandrakant Nakade | Director | 07 Sep 2021 | 5 Years 2 Months | Current |
| Amar Ankush Dhaygude | Director | 24 Oct 2022 | 4 Years 0 Months | Current |
| Siddharam Chandrakant Zendekar | Director | 24 Oct 2022 | 4 Years 0 Months | Current |
Peer comparison
Elara Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zenobia Pharmaceuticals Private Limited | ₹68.72 Lakh (FY 2021) | -42.0% | Kozhikode, Kerala, India | |||
| Dotsy Pharmaceuticals Private Limited | ₹68.7 Lakh (FY 2024) | 686991250.0% | New Delhi, Delhi, India | |||
| Elara Pharmaceuticals Private Limitedthis company | ₹68.52 Lakh (FY 2025) | ₹4.24 Lakh | 6.2% | 24.0% | Pune, Maharashtra, India | |
| Scinva Chemicals and Pharmaceuticals Private Limited | ₹68.23 Lakh (FY 2025) | 1569.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of Elara Pharmaceuticals Private Limited, buy the company report.
Auditor
Elara Pharmaceuticals Private Limited is audited by S R KULKARNI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R KULKARNI & ASSOCIATES | FY 2022 | 132688W |
Shareholding
The shareholding of Elara Pharmaceuticals Private Limited is on record for FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Elara Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.01 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Oct 2024 | 100986819 | State Bank of India | ₹13.01 Lakh | Open |
To see the full charge records of Elara Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Elara Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elara Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elara Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCE6368N1ZY | Maharashtra | Active | 10 Nov 2021 |
To see the full GST registrations and return filing status of Elara Pharmaceuticals Private Limited, buy the company report.
Recent activity
Elara Pharmaceuticals Private Limited has 7 board changes on record since 2021: 4 appointments and 3 cessations. The latest: Amar Ankush Dhaygude ceased to be Additional Director on 29 Sep 2023.
Charges
A charge with State Bank Of India of Rs. 13.01 Lakh registered on 04 Oct 2024 with Charge ID 100986819 was modified on 06 Dec 2025.
AGM
Elara Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elara Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with State Bank Of India amounted to Rs. 13.01 Lakh with Charge ID 100986819 was registered on 04 Oct 2024.
Ceased
Amar Ankush Dhaygude ceased to be Additional Director.
Ceased
Siddharam Chandrakant Zendekar ceased to be Additional Director.
Ceased
Nitin Vijaykumar Chinchure ceased to be Director.
Appointed
Amar Ankush Dhaygude was appointed as Director.
Appointed
Siddharam Chandrakant Zendekar was appointed as Director.
Appointed
Narayan Zendekar was appointed as Director.
Appointed
Sachin Chandrakant Nakade was appointed as Director.
Incorporation
07 Sep 2021
Elara Pharmaceuticals Private Limited was registered on 07 Sep 2021 with Roc Pune & aged 5 years 2 months as per MCA records.
Frequently asked questions
Elara Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 September 2021 (5+ years old) and is registered under CIN U24299PN2021PTC204056.
Elara Pharmaceuticals has 4 current directors:
- Narayan Zendekar - Director
- Sachin Chandrakant Nakade - Director
- Amar Ankush Dhaygude - Director
- Siddharam Chandrakant Zendekar - Director
The latest financial statements of Elara Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Elara Pharmaceuticals is 27AAGCE6368N1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Elara Pharmaceuticals is U24299PN2021PTC204056. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elara Pharmaceuticals was incorporated on 07 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Elara Pharmaceuticals by revenue are Zenobia Pharmaceuticals Private Limited, Dotsy Pharmaceuticals Private Limited, Scinva Chemicals and Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amar Ankush Dhaygude ceased to be Additional Director on 29 Sep 2023. Siddharam Chandrakant Zendekar ceased to be Additional Director on 29 Sep 2023. Nitin Vijaykumar Chinchure ceased to be Director on 18 Jan 2023. Elara Pharmaceuticals has 7 board changes on record in total.
Yes, Elara Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0163309).
The registered office of Elara Pharmaceuticals is at Gat No.1236 Datta Nagar 10th Mail Haveli Wadki, Pune, Maharashtra, India – 412308.
Elara Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages